US2016229914A1PendingUtilityA1

Method of treating a pathological syndrome

64
Assignee: EPSHTEIN OLEG ILIICHPriority: Jun 20, 2000Filed: Oct 7, 2015Published: Aug 11, 2016
Est. expiryJun 20, 2020(expired)· nominal 20-yr term from priority
Inventors:Oleg Iliich Epshtein
A61P 9/10A61P 43/00A61P 3/04A61P 9/00A61P 37/00C07K 16/22C07K 16/246A61P 25/34A61P 25/16C07K 16/26C07K 16/249A61P 31/12A61P 31/00A61P 25/36C07K 2317/73A61K 2039/505C07K 16/00A61P 25/32C07K 16/248C07K 2317/75C07K 16/241A61K 39/39583A61P 25/28A61K 2039/545C07K 16/28C07K 16/243A61P 25/30A61P 3/10A61P 29/00A61K 31/277C07K 16/40C07K 16/24C07K 16/245C07K 16/44A61P 25/24A61P 25/18C07K 2317/77A61K 41/0004C07K 16/2806
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of treating disorder or condition that relates to intracellular signal transmission of a neurotransmitter, comprising administration of an homeopathically potentized form of antibodies to an antigen, which antigen is a molecule capable of effecting the intracellular signal transmission of a neuroreceptor, in particular dopamine or serotonin.

Claims

exact text as granted — not AI-modified
1 - 28 . (canceled) 
     
     
         29 . A method of treating a disorder or condition that relates to intracellular signal transmission of dopamine in a patient, said method comprising administering to said patient in need thereof a homeopathically potentized form of an antibody to an antigen, which antigen is a molecule capable of effecting said intracellular signal transmission of dopamine. 
     
     
         30 . The method of  claim 29 , wherein said antigen is an endogenous biomolecule. 
     
     
         31 . The method of  claim 30 , wherein said endogenous biomolecule is dopamine. 
     
     
         32 . The method of  claim 29 , wherein said disorder or condition is schizophrenia. 
     
     
         33 . The method of  claim 29 , wherein said disorder or condition is tremors and gait disorders. 
     
     
         34 . The method of  claim 29 , wherein said disorder or condition is chronic gastritis. 
     
     
         35 . The method of  claim 29 , wherein said disorder or condition is night phobias. 
     
     
         36 . The method of  claim 29 , wherein said disorder or condition is Parkinson's disease. 
     
     
         37 . A method of treating a disorder or condition that relates to intracellular signal transmission of serotonin in a patient, said method comprising administering to said patient in need thereof a homeopathically potentized form of an antibody to an antigen, which antigen is a molecule capable of effecting said intracellular signal transmission of serotonin. 
     
     
         38 . The method of  claim 37 , wherein said antigen is an endogenous biomolecule. 
     
     
         39 . The method of  claim 38 , wherein said endogenous biomolecule is serotonin. 
     
     
         40 . The method of  claim 37 , wherein said disorder or condition is depression. 
     
     
         41 . The method of  claim 37 , wherein said disorder or condition is anxiety. 
     
     
         42 . The method of  claim 37 , wherein said disorder or condition is migraines. 
     
     
         43 . The method of  claim 37 , wherein said disorder or condition is insomnia. 
     
     
         44 . The method of  claim 37 , wherein said disorder or condition is aggression. 
     
     
         45 . The method of  claim 37 , wherein said disorder or condition is motion sickness. 
     
     
         46 . The method of  claim 37 , wherein said disorder or condition is pruritus. 
     
     
         47 . The method of  claim 37 , wherein said disorder or condition is obesity.

Join the waitlist — get patent alerts

Track US2016229914A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.